semaglutide trevogrumab and and garetosmab COURAGE Trial confirms potential to improve the quality of semaglutide-induced weight loss by preserving lean mass Are myostatin inhibitors the end – semaglutide and trevogrumab Regeneron's COURAGE

Symptoms can include itching, rash, or swelling at the injection site

Taken as a once-weekly injection Doses studied so far include: 1 mg, 4 mg, 8 mg, and up to 12 mg Gradual dose increases are used to help the body adjust and reduce side effects Because retatrutide is still in development, the exact dosing schedule could change before it becomes available, but the general approach is expected to feel similar to current GLP-1 medications

Statistical Analysis Sample size was not based on a formal statistical power calculation

Although muscle loss is a potential risk, there are strategies to minimize its impact: Prioritize Protein Intake Aim for 0.8 to 1.2 grams of protein per pound of lean body mass daily

Another category of gut-busters is antibiotics